Showing results (221-230 of 513) with videos related to

Sort By:
Pageof 52
Clinical Lung Cancer|January 15, 2013
Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinibJin Hyun Park, Tae Min Kim, Bhumsuk Keam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2022
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 TrialJiyun Lee, Jiae Koh, Hee Kyung Kim, et al.
American Journal of Clinical Oncology|June 11, 2011
Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung)Su-Jung Kim, Jin Won Kim, Do-Youn Oh, et al.
Cancer Chemotherapy and Pharmacology|May 25, 2011
Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trialSe Hyun Kim, Sang Joon Shin, Sun Young Kim, et al.
Cancer Science|March 30, 2010
First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictorsTae Min Kim, Ki Hwan Kim, Min Joung Lee, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 28, 2009
Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatinChul-Kee Park, Sung-Hye Park, Se-Hoon Lee, et al.
Chemotherapy|April 25, 2009
Preradiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective analysisJung Ho Han, Chul-Kee Park, Se-Hoon Lee, et al.
Cancer|April 7, 2021
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy ProgramSehhoon Park, Steve Olsen, Bo Mi Ku, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experienceYong-Pyo Lee, Byeong-Ho Jeong, Yeonghee Eun, et al.
BMC Cancer|December 19, 2009
Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapyChul-Kee Park, Se-Hoon Lee, Jung Ho Han, et al.
Pageof 52